Skip to main content
. 2023 Aug 2;13(33):23285–23307. doi: 10.1039/d3ra04007k

Toxicity study of the synthesized compounds.

Comp. Ames prediction Rat-male-FDA Carcinogenic potency TD50 (mouse)a Rat oral LD50b Rat chronic LOAELb Skin irritancy Ocular irritancy
15a Non-mutagen Non-carcinogen 23.973 1.785 0.046 Non-irritant Mild
15b 18.268 1.580 0.108
16 24.482 1.305 0.046
17 27.036 0.768 0.062
Sorafenib 19.236 0.823 0.005
a

Unit: mg kg−1 body weight per day.

b

Unit: g kg−1 body weight.